Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04831619Phase 3Completed
Phase 3, open-label, single-arm trial, sponsored by CHU de La Réunion. Primary endpoint: Number of endometriosis lesions diagnosed and locations compared to surgery. Started Dec 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04831619.